Annual CFF
$809.89 M
+$755.57 M+1390.92%
December 31, 2024
Summary
- As of March 13, 2025, DYN annual cash flow from financing activities is $809.89 million, with the most recent change of +$755.57 million (+1390.92%) on December 31, 2024.
- During the last 3 years, DYN annual CFF has risen by +$652.07 million (+413.17%).
- DYN annual CFF is now at all-time high.
Performance
DYN Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$3.64 M
-$14.37 M-79.81%
December 31, 2024
Summary
- As of March 13, 2025, DYN quarterly cash flow from financing activities is $3.64 million, with the most recent change of -$14.37 million (-79.81%) on December 31, 2024.
- Over the past year, DYN quarterly CFF has dropped by -$376.23 million (-99.04%).
- DYN quarterly CFF is now -99.11% below its all-time high of $408.39 million, reached on March 31, 2024.
Performance
DYN Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$809.89 M
+$3.49 M+0.43%
December 31, 2024
Summary
- As of March 13, 2025, DYN TTM cash flow from financing activities is $809.89 million, with the most recent change of +$3.49 million (+0.43%) on December 31, 2024.
- Over the past year, DYN TTM CFF has increased by +$21.04 million (+2.67%).
- DYN TTM CFF is now at all-time high.
Performance
DYN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
DYN Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1390.9% | -99.0% | +2.7% |
| 3 y3 years | +413.2% | -85.4% | +790.0% |
| 5 y5 years | +3951.7% | -85.4% | +790.0% |
DYN Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +2066.1% | -99.1% | >+9999.0% | at high | >+9999.0% |
| 5 y | 5-year | at high | +3951.7% | -99.1% | +132.5% | at high | >+9999.0% |
| alltime | all time | at high | +6419.8% | -99.1% | +132.5% | at high | >+9999.0% |
Dyne Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $809.89 M(+1390.9%) | $3.64 M(-79.8%) | $809.89 M(+0.4%) |
| Sep 2024 | - | $18.01 M(-95.3%) | $806.41 M(+2.2%) |
| Jun 2024 | - | $379.86 M(-7.0%) | $788.85 M(+81.8%) |
| Mar 2024 | - | $408.39 M(>+9900.0%) | $433.89 M(+698.7%) |
| Dec 2023 | $54.32 M(+45.3%) | $147.00 K(-67.6%) | $54.32 M(-40.6%) |
| Sep 2023 | - | $454.00 K(-98.2%) | $91.38 M(+0.4%) |
| Jun 2023 | - | $24.91 M(-13.6%) | $90.99 M(+37.5%) |
| Mar 2023 | - | $28.82 M(-22.5%) | $66.19 M(+77.0%) |
| Dec 2022 | $37.39 M | $37.20 M(>+9900.0%) | $37.39 M(>+9900.0%) |
| Sep 2022 | - | $70.00 K(-29.3%) | $276.00 K(-58.4%) |
| Jun 2022 | - | $99.00 K(+450.0%) | $663.00 K(+12.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $18.00 K(-79.8%) | $589.00 K(-99.6%) |
| Dec 2021 | $157.82 M(-58.5%) | $89.00 K(-80.5%) | $157.82 M(+7.7%) |
| Sep 2021 | - | $457.00 K(+1728.0%) | $146.54 M(-72.1%) |
| Jun 2021 | - | $25.00 K(-100.0%) | $526.06 M(+0.0%) |
| Mar 2021 | - | $157.25 M(-1504.8%) | $526.03 M(+38.2%) |
| Dec 2020 | $380.69 M(+1804.5%) | -$11.19 M(-102.9%) | $380.69 M(-2.9%) |
| Sep 2020 | - | $379.98 M(>+9900.0%) | $391.88 M(+3190.9%) |
| Jun 2020 | - | $0.00(-100.0%) | $11.91 M(0.0%) |
| Mar 2020 | - | $11.91 M | $11.91 M |
| Dec 2019 | $19.99 M(+60.9%) | - | - |
| Dec 2018 | $12.42 M | - | - |
FAQ
- What is Dyne Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Dyne Therapeutics?
- What is Dyne Therapeutics annual CFF year-on-year change?
- What is Dyne Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Dyne Therapeutics?
- What is Dyne Therapeutics quarterly CFF year-on-year change?
- What is Dyne Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Dyne Therapeutics?
- What is Dyne Therapeutics TTM CFF year-on-year change?
What is Dyne Therapeutics annual cash flow from financing activities?
The current annual CFF of DYN is $809.89 M
What is the all time high annual CFF for Dyne Therapeutics?
Dyne Therapeutics all-time high annual cash flow from financing activities is $809.89 M
What is Dyne Therapeutics annual CFF year-on-year change?
Over the past year, DYN annual cash flow from financing activities has changed by +$755.57 M (+1390.92%)
What is Dyne Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of DYN is $3.64 M
What is the all time high quarterly CFF for Dyne Therapeutics?
Dyne Therapeutics all-time high quarterly cash flow from financing activities is $408.39 M
What is Dyne Therapeutics quarterly CFF year-on-year change?
Over the past year, DYN quarterly cash flow from financing activities has changed by -$376.23 M (-99.04%)
What is Dyne Therapeutics TTM cash flow from financing activities?
The current TTM CFF of DYN is $809.89 M
What is the all time high TTM CFF for Dyne Therapeutics?
Dyne Therapeutics all-time high TTM cash flow from financing activities is $809.89 M
What is Dyne Therapeutics TTM CFF year-on-year change?
Over the past year, DYN TTM cash flow from financing activities has changed by +$21.04 M (+2.67%)